A phase III, investigator blind, randomized, multicenter study to evaluate the efficacy and safety of APC-231 [amoxicillin] sprinkle QD for 7 days vs penicillin VK [phenoxymethylpenicllin potassium] 10 mg/kg QID for 10 days in pediatric patients with Streptococcus pyogenes

Trial Profile

A phase III, investigator blind, randomized, multicenter study to evaluate the efficacy and safety of APC-231 [amoxicillin] sprinkle QD for 7 days vs penicillin VK [phenoxymethylpenicllin potassium] 10 mg/kg QID for 10 days in pediatric patients with Streptococcus pyogenes

Completed
Phase of Trial: Phase III

Latest Information Update: 29 Sep 2005

At a glance

  • Drugs Amoxicillin; Phenoxymethylpenicillin potassium
  • Indications Pharyngitis; Streptococcal infections; Tonsillitis
  • Focus Therapeutic Use
  • Most Recent Events

    • 29 Sep 2005 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top